https://www.selleckchem.com/pr....oducts/Masitinib-(AB
05). The improved group on KAQLQ showed a significant improvement in FEV1% (p 0.001). Omalizumab can be considered a biological treatment for Korean patients with severe allergic asthma. It is recommended to consider omalizumab as add-on therapy in patients with high baseline total IgE levels and severe asthma symptoms. Omalizumab can be considered a biological treatment for Korean patients with severe allergic asthma. It is recommended to consider omalizumab as add-on therapy in patients with high baseline total IgE lev
Like
Comment
Share
